University of Colorado Hospital- Anschutz Outpatient Pavilion

Aurora, Colorado 80045

1 studies enrolling now · 15 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Brain Metastases, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Focal Epilepsy, Parkinson Disease, Squamous Cell Carcinoma of the Head and Neck, Tonic-Clonic Seizures, Tremor

Studies at this site

• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. — Running, not enrolling
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease — Completed
• Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer — Completed
• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling
• A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) — Stopped early
• An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis — Stopped early
• Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) — Stopped early
• A Study for Patients Who Completed VITALITY-ALS (CY 4031) — Completed
• A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year — Completed
• Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer — Completed
• Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults — Completed